Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial

詳細情報 詳細情報について

• CRID

  1360016868133232640

• DOI

  10.1016/s2213-2600(21)00226-5

• ISSN

  22132600

• Web Site

  https://api.elsevier.com/content/article/PII:S2213260021002265?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S2213260021002265?httpAccept=text/plain

• データソース種別

  • Crossref